Atlanta, Georgia


M. Brandon Smith

FDA Seeks to Prevent Pharmaceutical Companies from Abusing ‘Orphan Drug’ Law

Recently, I discussed a couple of reports that have come to light, potentially exposing the shortcomings of an FDA policy on “fast tracking” the approval of certain new drugs. Now, the FDA is in the middle of a large operation […]

M. Brandon Smith

Could the FDA Be Approving Drugs Based on Questionable Evidence?

Every time you turn on the television, you are most likely bombarded by a barrage of advertisements for prescription drugs. While you might be wary of marketer’s claims and promises as to their effect, you can at least rest assured […]

M. Brandon Smith

‘My Skin Was Melting’: One Woman’s Horror Story and the Generic Prescription Drug for Lamictal that Caused It.

In 2014, A young woman in Snellville, Georgia visited her doctor with claims of depression. Her physician prescribed lamotrigine, also marketed under the tradename Lamictal, a mood-stabilizing anticonvulsant best known for controlling seizures with those who suffer from epilepsy. While […]

M. Brandon Smith

Ovarian Cancer Victim Awarded Over $70 Million In Third Jury Trial Over Talcum Powder

In the third consecutive talcum powder trial, a St. Louis City jury award plaintiff Deborah Giannecchini $2.57 million in compensatory damages and 67.5 million in punitive damages against Johnson & Johnson and the Imerys Talc America defendants for their talc-containing […]

Richard R. Schlueter

New Stryker LFit V40 Femoral Head Hip Recall Coming Soon

Last week Childers, Schlueter & Smith, LLC published the Australian Health Hazard alert regarding the Stryker LFIT  V40 Femoral head.  CSS Firm has learned a list of affected lot numbers that includes hundreds of Lot and Item Numbers by Stryker. […]

M. Brandon Smith

Invokana and Farxiga Increase Warnings Over Acute Kidney Failure

The FDA just released more information on Invokana and Farxiga related to acute kidney failure. A topic and drug Childers, Schlueter & Smith have been investigating for a long time now.   Check out our: Top 10 Things Invokana Patients […]

M. Brandon Smith

Canadian Invokana Lawsuit Seeks $1 Billion in Damages

An Invokana lawsuit filed last year in Canada seeks $1 billion in damages against drug maker Janssen Pharmaceuticals. The lawsuit, filed in September 2015 at the Ontario Superior Court of Justice, seeks class-action status, which is expected to be determined […]

M. Brandon Smith

Concerns About Safety of Diabetes Drug Invokana Continue to be Raised

The diabetes drug Invokana was introduced to the U.S. market in March 2013 and quickly became the go-to type 2 diabetes treatment, although the safety of the medication became a point of contention relatively quickly. In May 2015, the Institute […]

M. Brandon Smith

40 Xarelto Bellwether Cases to be Selected, Says Judge

According to a case management order issued by U.S. District Judge Eldon Fallon, 40 cases will be chosen for the Xarelto bellwether pool, with each side selecting 10 cases and an additional 20 chosen randomly. According to Judge Fallon’s plan: […]

Andy Childers

Parties Select Xarelto Bellwether Cases, Litigation Moves Forward

The U.S. District Court in the Eastern District of Louisiana has started the process of selecting 40 cases for the bellwether trial pool. As required by an order dated December 17, 2015, the parties in the Xarelto multidistrict litigation (MDL) […]